← Leaderboards
Konstantin G Birukov
University Of Maryland Baltimore
$17,515,935
Attributed
$17,515,935
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$17,515,935 · 8
By mechanism
R01$15,512,861 · 5
P01$1,609,620 · 1
R56$383,454 · 1
R13$10,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Daniel Joseph Prantner$368,936
- Maegen A. Borzok$1,145,824
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungMolecularFunctional DisorderLung InjuryMediatingPermeabilitySignal TransductionCellsBlood VesselsInflammatoryAnimal ModelInflammationLeadPathway InteractionsIn VitroPhospholipidsProteinsLinkCell MembraneAgonistLung InflammationEndotheliumPathologicComplex
Grant awards (49)
Control of lung permeability by oxidized phospholipids$574,522
R01 · FY2023 · HL · contact PI
Modulation of inflammation in aging lung$384,615
R01 · FY2023 · HL · contact PI
Control of lung permeability by oxidized phospholipids$574,522
R01 · FY2022 · HL · contact PI
Modulation of inflammation in aging lung$384,343
R01 · FY2022 · HL · contact PI
Control of lung permeability by oxidized phospholipids$574,522
R01 · FY2021 · HL · contact PI
Modulation of inflammation in aging lung$383,634
R01 · FY2021 · HL · contact PI
Control of lung permeability by oxidized phospholipids$574,437
R01 · FY2020 · HL · contact PI
Molecular control of lung endothelial barrier function in ALI$386,250
R01 · FY2020 · HL · contact PI
Modulation of inflammation in aging lung$383,634
R01 · FY2020 · HL · contact PI
Phospholipidomics and inflammation in sepsis$293,550
R01 · FY2020 · GM · contact PI
Molecular control of lung endothelial barrier function in ALI$386,250
R01 · FY2019 · HL · contact PI
Phospholipidomics and inflammation in sepsis$293,550
R01 · FY2019 · GM · contact PI
Molecular control of lung endothelial barrier function in ALI$386,250
R01 · FY2018 · HL · contact PI
Phospholipidomics and inflammation in sepsis$293,550
R01 · FY2018 · GM · contact PI
Control of Lung Permeability by Oxidized Phospholipids$386,250
R01 · FY2017 · HL · contact PI
Molecular control of lung endothelial barrier function in ALI$385,938
R01 · FY2017 · HL · contact PI
Phospholipidomics and inflammation in sepsis$293,550
R01 · FY2017 · GM · contact PI
2017 Grover Conference$10,000
R13 · FY2017 · HL · contact PI
Control of Lung Permeability by Oxidized Phospholipids$395,000
R01 · FY2016 · HL · contact PI
Mechanisms of Prostacyclin-Mediated Lung Endothelial Barrier Protection$389,075
R01 · FY2015 · HL · contact PI
Control of Lung Permeability by Oxidized Phospholipids$389,075
R01 · FY2015 · HL · contact PI
Mechanisms of ALI exacerbation in the aging lung$322,597
R56 · FY2015 · AG · contact PI
Mechanisms of ALI exacerbation in the aging lung$60,857
R56 · FY2015 · AG · contact PI
Control of Lung Permeability by Oxidized Phospholipids$395,000
R01 · FY2014 · HL · contact PI
Mechanisms of Prostacyclin-Mediated Lung Endothelial Barrier Protection$387,100
R01 · FY2014 · HL · contact PI
Mechanisms of Prostacyclin-Mediated Lung Endothelial Barrier Protection$376,040
R01 · FY2013 · HL · contact PI
Mechanisms of Prostacyclin-Mediated Lung Endothelial Barrier Protection$395,000
R01 · FY2012 · HL · contact PI
Control of Lung Permeability by Oxidized Phospholipids$386,100
R01 · FY2012 · HL · contact PI
Mechanotransduction Pathways of Endothelial Barrier Regulation$300,642
P01 · FY2012 · HL · contact PI
Control of Lung Permeability by Oxidized Phospholipids$390,000
R01 · FY2011 · HL · contact PI
Mechanisms of Prostacyclin-Mediated Lung Endothelial Barrier Protection$385,000
R01 · FY2011 · HL · contact PI
Mechanotransduction Pathways of Endothelial Barrier Regulation$300,642
P01 · FY2011 · HL · contact PI
Control of Lung Permeability by Oxidized Phospholipids$390,000
R01 · FY2010 · HL · contact PI
Mechanisms of Prostacyclin-Mediated Lung Endothelial Barrier Protection$385,000
R01 · FY2010 · HL · contact PI
Mechanotransduction Pathways of Endothelial Barrier Regulation$338,871
P01 · FY2010 · HL · contact PI
Control of Lung Permeability by Oxidized Phospholipids$390,000
R01 · FY2009 · HL · contact PI
Mechanisms of Prostacyclin-Mediated Lung Endothelial Barrier Protection$385,000
R01 · FY2009 · HL · contact PI
Mechanotransduction Pathways of Endothelial Barrier Regulation$331,317
P01 · FY2009 · HL · contact PI
Mechanisms of Prostacyclin-Mediated Lung Endothelial Barrier Protection$385,000
R01 · FY2008 · HL · contact PI
Mechanotransduction Pathways of Endothelial Barrier Regulation$338,148
P01 · FY2008 · HL · contact PI
Control of lung permeability by oxidized phospholipids$327,478
R01 · FY2007 · HL · contact PI
Mechanochemical regulation of endothelial permeability$327,477
R01 · FY2007 · HL · contact PI
Mechanochemical regulation of endothelial permeability$337,258
R01 · FY2006 · HL · contact PI
Control of lung permeability by oxidized phospholipids$336,892
R01 · FY2006 · HL · contact PI
Mechanochemical regulation of endothelial permeability$343,125
R01 · FY2005 · HL
Control of lung permeability by oxidized phospholipids$343,123
R01 · FY2005 · HL
Control of lung permeability by oxidized phospholipids$1
R01 · FY2005 · HL
Control of lung permeability by oxidized phospholipids$367,875
R01 · FY2004 · HL
Mechanochemical regulation of endothelial permeability$367,875
R01 · FY2004 · HL